DEFINITION OF THE HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENT BY IMMUNOLOGICAL PHENOTYPING WITH MONOCLONAL-ANTIBODIES

被引：0
|
作者：
ZIPF, TF
FOX, RI
DILLEY, J
LEVY, R
机构：
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED ONCOL,STANFORD,CA 94305
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,STANFORD,CA 94305
[3] STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST LABS,STANFORD,CA 94305
[4] STANFORD UNIV,CHILDRENS HOSP,DIV HEMATOL ONCOL,STANFORD,CA 94305
来源：
CANCER RESEARCH | 1981年 / 41卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4786 / 4789
页数：4
相关论文
共 50 条
  • [21] RECATEGORIZING CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA WITH MONOCLONAL-ANTIBODIES TO HUMAN T-CELLS
    SONDEL, PM
    BORCHERDING, W
    SHAHIDI, NT
    GANICK, DJ
    SCHULTZ, JC
    HONG, R
    BLOOD, 1981, 57 (06) : 1135 - 1137
  • [22] RELEVANCE OF MONOCLONAL-ANTIBODIES IN THE DIAGNOSIS OF UNUSUAL T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    FOA, R
    CAPPIO, FC
    CAMPANA, D
    FIERRO, MT
    BERGUI, L
    GIUBELLINO, MC
    LUSSO, P
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1983, 30 (04): : 303 - 307
  • [23] MYELOABLATIVE THERAPY WITH MONOCLONAL-ANTIBODY PURGED MARROW IN HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA
    SIMONSSON, B
    BURNETT, AK
    HANN, I
    PRENTICE, HG
    GIBSON, B
    LONNERHOLM, G
    SMEDMYR, B
    MORRISON, A
    TODD, A
    TOTTERMAN, T
    OBERG, G
    CAMPANA, D
    JANOSSY, G
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 560 - 560
  • [24] TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA WITH HIGH-RISK OF RELAPSE
    JANKASCHAUB, GE
    WINKLER, K
    KIRSTEIN, Z
    HOBEL, U
    GRAUBNER, U
    GUTIAR, P
    HAAS, RJ
    JURGENS, H
    SPAAR, HJ
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1991, 36 (10): : 3 - 7
  • [25] RESULTS OF TREATMENT OF HIGH-RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    KENDE, G
    ELNAJJAR, K
    BENBASSAT, I
    NEUMAN, Y
    BALLIN, A
    RAMOT, B
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (01): : 49 - 52
  • [26] USE OF MONOCLONAL-ANTIBODIES TO IDENTIFY CEREBROSPINAL-FLUID LYMPHOBLASTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HOMANS, AC
    FORMAN, EN
    BARKER, BE
    BLOOD, 1985, 66 (06) : 1321 - 1325
  • [27] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA BY FLOW-CYTOMETRY WITH MONOCLONAL-ANTIBODIES
    IMAMURA, N
    KURAMOTO, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (04) : 332 - 334
  • [28] MYELOABLATIVE THERAPY WITH MONOCLONAL-ANTIBODY PURGED MARROW RESCUE IN HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA
    SIMONSSON, B
    BURNETT, AK
    HANN, I
    PRENTICE, HG
    GIBSON, B
    LONNERHOLM, G
    SMEDMYR, B
    MORRISON, A
    TODD, A
    TOTTERMAN, T
    OBERG, G
    CAMPANA, D
    JANOSSY, G
    BONE MARROW TRANSPLANTATION, 1988, 3 : 75 - 75
  • [29] BONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA
    HERZIG, RH
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 617 - 617
  • [30] CLINICAL USEFULNESS OF MONOCLONAL-ANTIBODY PHENOTYPING IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    KERSEY, J
    GOLDMAN, A
    ABRAMSON, C
    NESBIT, M
    PERRY, G
    GAJLPECZALSKA, K
    LEBIEN, T
    LANCET, 1982, 2 (8313): : 1419 - 1423
12345